FDA and EMA to Host Orphan Product Designation and Grant Workshop

Summary

The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) will co-host a workshop to discuss orphan product designation and grant procedures, aiming to facilitate access to innovative treatments for rare diseases.